MIC Capital Management UK LLP
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 10, 2026), MIC Capital Management UK LLP reported 16 stock positions worth $394.3 million. Its top holding was Hayward (HAYW) at 27.1% of the portfolio, followed by Revolution Medicines (RVMD, 25.3%) and Recursion Pharmaceuticals-A (RXRX, 9.0%). Compared with Q1 2026, it opened 3 new positions, sold out of 1, added to 1 and reduced 3. The biggest buy was a new position in Alibaba Group Holding-SP ADR (BABA) and the biggest sale Klarna (KLAR, shares −69%).
- Most Recent 13F
- Q2 2026
- Location
- LONDON, X0
- CIK
- 0001889830
- Portfolio Value
- $394.3M (Q2 2026)
- SEC Filing
- 0001889830-26-000003 ↗ filed Aug 10, 2026
Holdings Value
Holdings 16 stocks · $394.3M
| HAYW Hayward Holdings Inc. | 27.09% | 6,171,527 | $106.8M | Reduce -6.1% |
| RVMD Revolution Medicines Inc. | 25.25% | 531,733 | $99.6M | Reduce -33.2% |
| RXRX Recursion Pharmaceuticals-A | 8.98% | 9,644,033 | $35.4M | Add +0.0% |
| QSR Restaurant Brands Intern | 7.10% | 386,203 | $28.0M | No change |
| CPNG Coupang Inc. | 6.22% | 1,412,946 | $24.5M | No change |
| GRAB Grab Holdings Ltd. Class A | 4.78% | 5,000,000 | $18.9M | No change |
| META Meta Platforms Inc. Class A | 4.76% | 33,300 | $18.8M | No change |
| KLAR Klarna Group PLC | 4.38% | 852,498 | $17.3M | Reduce -68.6% |
| BABA Alibaba Group Holding-SP ADR | 3.65% | 150,000 | $14.4M | New |
| COF Capital One Financial Corp. | 2.44% | 48,011 | $9.6M | New |
| NMRA Neumora Therapeutics Inc. | 1.92% | 4,460,700 | $7.6M | No change |
| MNDY Monday.com Ltd. | 1.21% | 66,000 | $4.8M | No change |
| RKLB Rocket Lab Corp. | 0.92% | 35,628 | $3.6M | No change |
| ACHR Archer Aviation Inc. Class A | 0.84% | 700,000 | $3.3M | No change |
| LYEL Lyell Immunopharma Inc. | 0.31% | 87,028 | $1.2M | No change |
| BLLN Billiontoone Inc. Class A | 0.15% | 4,892 | $587K | New |
Portfolio Sells Q1 2026 → Q2 2026
Portfolio Buys Q1 2026 → Q2 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $394.3M | HAYW, RVMD, RXRX, QSR, CPNG |
| Q1 2026 | 14 | $352.5M | HAYW, RVMD, KLAR, RXRX, QSR |
| Q4 2025 | 13 | $441.3M | HAYW, KLAR, RVMD, RXRX, CPNG |
| Q3 2025 | 13 | $500.3M | HAYW, KLAR, RXRX, CPNG, GRAB |
| Q2 2025 | 13 | $509.3M | HAYW, MTSR, RXRX, CPNG, QSR |
| Q1 2025 | 14 | $490.8M | HAYW, MTSR, RXRX, CPNG, QSR |
| Q4 2024 | 14 | $706.3M | EDR, HAYW, RXRX, NMRA, CPNG |
| Q3 2024 | 15 | $720.1M | EDR, HAYW, NMRA, RXRX, CPNG |
| Q2 2024 | 12 | $460.0M | EDR, RXRX, NMRA, CPNG, QSR |
| Q1 2024 | 16 | $526.5M | EDR, RXRX, NMRA, QSR, CPNG |